Award Notice - Celltheon Corporation Anti-Carfentanil monoclonal antibody (mAb)
Award Notice Posted
- Solicitation number
- HT942524P0148
- Agency
-
Defense Health Agency
Department of Defense
- Awarded
- to Celltheon Corporation
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- HT942524P0148 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Aberdeen Proving Ground, Maryland, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice announces the award of Contract HT942524P0148 to Celltheon Corporation by the Defense Health Agency for the procurement of over 4 grams of an anti-carfentanil monoclonal antibody (mAb) at a total cost of $60,000. The mAb will be used to support an NIH Interagency Agreement research study involving non-human primate research, and the delivery date is June 1, 2025. The procurement is being made under the simplified acquisition threshold due to Celltheon's proprietary technology and the research study's requirements.
Notice text
Awarded contract HT942524P0148 to CELLTHEON CORPORATION for 60000.00 on 2024-09-05.
Files
| File | Type | Posted |
|---|---|---|
| A02-Limiting Competition_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Notice of Intent to Sole Source - Celltheon Corporation Anti-Carfentanil monoclonal antibody (mAb) | Special Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity